HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pseudocatalytic scavenging of the nerve agent VX with human blood components and the oximes obidoxime and HI-6.

Abstract
Despite six decades of extensive research in medical countermeasures against nerve agent poisoning, a broad spectrum acetylcholinesterase (AChE) reactivator is not yet available. One current approach is directed toward synthesizing oximes with high affinity and reactivatability toward butyrylcholinesterase (BChE) in plasma to generate an effective pseudocatalytic scavenger. An interim solution could be the administration of external AChE or BChE from blood products to augment pseudocatalytic scavenging with slower but clinically approved oximes to decrease nerve agent concentrations in the body. We here semiquantitatively investigate the ability of obidoxime and HI-6 to decrease the inhibitory activity of VX with human AChE and BChE from whole blood, erythrocyte membranes, erythrocytes, plasma, clinically available fresh frozen plasma and packed red blood cells. The main findings are that whole blood showed a VX concentration-dependent decrease in inhibitory activity with HI-6 being more potent than obidoxime. Using erythrocytes and erythrocyte membranes again, HI-6 was more potent compared to obidoxime. With freshly prepared plasma, obidoxime and HI-6 showed comparable results for the decrease in VX. The use of the clinically available blood products revealed that packed red blood cells showed similar kinetics as fresh erythrocytes. Fresh frozen plasma resulted in a slower and incomplete decrease in inhibitory plasma compared to freshly prepared plasma. In conclusion, the administration of blood products in combination with available oximes augments pseudocatalytic scavenging and might be useful to decrease the body load of persistent, highly toxic nerve agents.
AuthorsTimo Wille, Jens von der Wellen, Horst Thiermann, Franz Worek
JournalArchives of toxicology (Arch Toxicol) Vol. 91 Issue 3 Pg. 1309-1318 (Mar 2017) ISSN: 1432-0738 [Electronic] Germany
PMID27358236 (Publication Type: Journal Article)
Chemical References
  • Chemical Warfare Agents
  • Cholinesterase Inhibitors
  • Cholinesterase Reactivators
  • Organothiophosphorus Compounds
  • Oximes
  • Pyridinium Compounds
  • Obidoxime Chloride
  • VX
  • Acetylcholinesterase
  • Butyrylcholinesterase
  • asoxime chloride
Topics
  • Acetylcholinesterase (blood, metabolism)
  • Binding Sites
  • Blood Specimen Collection
  • Butyrylcholinesterase (blood, metabolism)
  • Chemical Warfare Agents (toxicity)
  • Cholinesterase Inhibitors (toxicity)
  • Cholinesterase Reactivators (pharmacology)
  • Erythrocyte Membrane (drug effects)
  • Erythrocytes (drug effects, metabolism)
  • Freezing
  • Humans
  • Inactivation, Metabolic
  • Obidoxime Chloride (pharmacology)
  • Organothiophosphorus Compounds (toxicity)
  • Oximes (pharmacology)
  • Pyridinium Compounds (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: